Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Paoletti

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction CarcinomaMatthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
International Journal of Cancer|April 29, 2006
Breast cancer risk in relation to abortion: Results from the EPIC studyGillian K Reeves, Sau-Wan Kan, Tim Key, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2020
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeRomain Cohen, Dewi Vernerey, Carine Bellera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trialSusanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction CarcinomaMatthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
International Journal of Cancer|April 29, 2006
Breast cancer risk in relation to abortion: Results from the EPIC studyGillian K Reeves, Sau-Wan Kan, Tim Key, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2020
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeRomain Cohen, Dewi Vernerey, Carine Bellera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trialSusanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Pageof 15